Lupin gets USFDA nod to market Tetrabenazine tablets Ruby Khatun Khatun24 April 2018 10:15 AM ISTNew Delhi: Drug firm Lupin said it has received approval from the US health regulator to market in America its Tetrabenazine tablets used for the...
GSK Consumer Healthcare appoints Rahul Kapoor as Executive Vice President-HR Ruby Khatun Khatun24 April 2018 10:00 AM ISTNew Delhi: GSK Consumer Healthcare said it has appointed Rahul Kapoor as executive vice-president-HR for India sub-continent (ISC) region.Kapoor will...
FDA panel against higher dose of Lilly-Incyte arthritis drug Ruby Khatun Khatun24 April 2018 9:45 AM ISTAn arthritis drug developed by Eli Lilly & Co and Incyte Corp should not be approved at a 4-milligram dose, advisers to the U.S. FDA voted, in a...
FDA declines to approve Pfizer biosimilar of Roche's cancer drug Ruby Khatun Khatun24 April 2018 9:30 AM ISTPfizer Inc said U.S. regulators declined to approve the company’s biosimilar of Roche’s blockbuster treatment for breast cancer, Herceptin and sought...
PIL in HC against new tender to empanel chemists under CGHS Ruby Khatun Khatun23 April 2018 10:30 AM ISTNew Delhi: The Delhi High Court has sought the response of the Centre on a PIL challenging an e-tender issued for empanelment of authorised local...
Novartis appoints John Tsai as Head of Global Drug Development and CMO Ruby Khatun Khatun23 April 2018 10:15 AM ISTBasel: Novartis announced the appointment of John Tsai, M.D. as Head of Global Drug Development (GDD) and Chief Medical Officer.Dr. Tsai will join...
Merck seeks partners for cancer and immune system drugs Ruby Khatun Khatun23 April 2018 10:00 AM ISTFRANKFURT: Merck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing deals to...
Asembia expands collaboration with Pfizer oncology Ruby Khatun Khatun23 April 2018 9:45 AM ISTAsembia members can now gain expanded access to Pfizer Oncology defined distribution oncology products for qualified hospital and health system...
Biogen boosts investment in neurology with 1 billion dollar Ionis deal Ruby Khatun Khatun23 April 2018 9:30 AM ISTBiogen Inc struck a $1 billion neurology drug development deal with Ionis Pharmaceuticals, expanding a partnership that developed the company’s...
Glenmark Pharma gets USFDA nod for scalp and skin treatment drug Ruby Khatun Khatun22 April 2018 10:30 AM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for a generic version of Temovate Topical Solution used...
USFDA completes Ghaziabad plant inspection, no observations issued: Unichem Ruby Khatun Khatun22 April 2018 10:15 AM ISTNew Delhi: Drug firm Unichem Laboratories said it has not received any observations from the US health regulator after completion of inspection of its...
FDA approves Rigel Pharmaceuticals drug for rare bleeding disorder Ruby Khatun Khatun22 April 2018 10:00 AM ISTThe U.S. Food and Drug Administration (FDA) on Tuesday approved Rigel Pharmaceuticals Inc’s treatment for a rare bleeding disorder.Rigel’s Tavalisse...
